Intelsius Launches New Patient Safety Products
BASEL, Switzerland – Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, announces the launch of its new Thermotrek range of products.
Thermotrek systems are a range of insulated, patient carry cases designed for movement of temperature sensitive medications either being tested in clinical trials or for approved and marketed medicines used by patients. The success or failure of clinical trials often depends on crucial passive climate controls to ensure the efficacy of medicines. In commercially available temperature sensitive medicines the systems ensure the patient’s investment in treatment is not wasted while ensuring efficacy of the medicine. Thermotrek systems are qualified to maintain contents at the required temperature for up to 24 hours and designed to give many months of use.
The first two Thermotrek solutions are constructed with proprietary materials which provide a high level of resistance to tears or abrasions while providing stain and water resistance.
Each case is ergonomically designed to have a minimum impact on the patient’s daily life and enable comfortable transportation of medicine. In addition, its discreet design keeps the contents confidential. With the Thermotrek range, Intelsius continues to lead the way in developing solutions that ensure patient safety.
“Keeping patients safe and helping ensure successful clinical trial outcomes are the primary reasons for creating the Thermotrek line of products,” said David Walsh, chief executive officer of Intelsius. “We are proud to lead the way in the effort to provide easy to use, technically advanced solutions to the life science industry,” said Walsh.
Source: Intelsius www.intelsius.com